{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:53:02Z","timestamp":1792439582837,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-017-0722-z","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T11:50:02Z","timestamp":1515585002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaowei","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-7057","authenticated-orcid":false,"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"issue":"4","key":"722_CR1","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742cf6","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation. 2013;127(4):e362\u2013425.","journal-title":"Circulation"},{"issue":"1","key":"722_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3909\/ricm0699","volume":"15","author":"A Feher","year":"2014","unstructured":"Feher A, Chen SY, Bagi Z, Arora V. Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation. Rev Cardiovasc Med. 2014;15(1):38\u201351.","journal-title":"Rev Cardiovasc Med"},{"issue":"9","key":"722_CR3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","volume":"7","author":"YS Hamirani","year":"2014","unstructured":"Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2014;7(9):940\u201352.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"722_CR4","first-page":"587","volume":"26","author":"S Sattur","year":"2014","unstructured":"Sattur S, Sarwar B, Sacchi TJ, Brener SJ. Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review. J Invasive Cardiol. 2014;26(11):587\u2013U50.","journal-title":"J Invasive Cardiol."},{"issue":"5","key":"722_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2459\/JCM.0000000000000178","volume":"17","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Cosentino N, Spaziani C, Loria V, Fracassi F, Roberto M, et al. Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role. J Cardiovasc Med (Hagerstown). 2016;17(5):382\u201391.","journal-title":"J Cardiovasc Med (Hagerstown)."},{"issue":"24","key":"722_CR6","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/CIRCULATIONAHA.107.742312","volume":"117","author":"R Jaffe","year":"2008","unstructured":"Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008;117(24):3152\u20136.","journal-title":"Circulation"},{"issue":"24","key":"722_CR7","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/eurheartj\/ehw186","volume":"37","author":"DJ Kumbhani","year":"2016","unstructured":"Kumbhani DJ, de Lemos JA. Finding an effective treatment for microvascular obstruction in STEMI: a road to perdition? Eur Heart J. 2016;37(24):1920\u20132.","journal-title":"Eur Heart J"},{"key":"722_CR8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijcard.2015.11.086","volume":"203","author":"A Polimeni","year":"2016","unstructured":"Polimeni A, De Rosa S, Sabatino J, Sorrentino S, Indolfi C. Impact of intracoronary adenosine administration during primary PCI: a meta-analysis. Int J Cardiol. 2016;203:1032\u201341.","journal-title":"Int J Cardiol"},{"issue":"32","key":"722_CR9","doi-asserted-by":"crossref","first-page":"e1279","DOI":"10.1097\/MD.0000000000001279","volume":"94","author":"Q Gao","year":"2015","unstructured":"Gao Q, Yang B, Guo Y, Zheng F. Efficacy of adenosine in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2015;94(32):e1279.","journal-title":"Medicine (Baltimore)"},{"key":"722_CR10","first-page":"382086","volume":"2015","author":"L Wang","year":"2015","unstructured":"Wang L, Cheng Z, Gu Y, Peng D. Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials. Biomed Res Int. 2015;2015:382086.","journal-title":"Biomed Res Int"},{"issue":"10","key":"722_CR11","doi-asserted-by":"crossref","first-page":"e78231","DOI":"10.1371\/journal.pone.0078231","volume":"8","author":"M Wu","year":"2013","unstructured":"Wu M, Huang Z, Xie H, Zhou Z. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. PLoS One. 2013;8(10):e78231.","journal-title":"PLoS One"},{"issue":"4","key":"722_CR12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joic.12133","volume":"27","author":"S Zhao","year":"2014","unstructured":"Zhao S, Qi G, Tian W, Chen L, Sun Y. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis. J Interv Cardiol. 2014;27(4):356\u201364.","journal-title":"J Interv Cardiol"},{"issue":"2","key":"722_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jat.1154","volume":"27","author":"JM Poupko","year":"2007","unstructured":"Poupko JM, Baskin SI, Moore E. The pharmacological properties of anisodamine. J Appl Toxicol. 2007;27(2):116\u201321.","journal-title":"J Appl Toxicol"},{"issue":"3","key":"722_CR14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-015-0642-4","volume":"73","author":"K Xing","year":"2015","unstructured":"Xing K, Fu X, Jiang L, Wang Y, Li W, Gu X, et al. Cardioprotective effect of anisodamine against myocardial ischemia injury and its influence on cardiomyocytes apoptosis. Cell Biochem Biophys. 2015;73(3):707\u201316.","journal-title":"Cell Biochem Biophys"},{"issue":"5","key":"722_CR15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1142\/S0192415X11009251","volume":"39","author":"XL Yin","year":"2011","unstructured":"Yin XL, Shen H, Zhang W, Yang Y. Inhibition of endoplasm reticulum stress by anisodamine protects against myocardial injury after cardiac arrest and resuscitation in rats. Am J Chin Med. 2011;39(5):853\u201366.","journal-title":"Am J Chin Med"},{"issue":"14","key":"722_CR16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00029330-200707020-00004","volume":"120","author":"XH Fu","year":"2007","unstructured":"Fu XH, Fan WZ, Gu XS, Wei YY, Jiang YF, Wu WL, et al. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction. Chin Med J. 2007;120(14):1226\u201331.","journal-title":"Chin Med J"},{"issue":"7387","key":"722_CR17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","volume":"326","author":"F Song","year":"2003","unstructured":"Song F, Altman DG, Glenny A-M, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326(7387):472.","journal-title":"BMJ"},{"issue":"2","key":"722_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163\u201371.","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"722_CR19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","volume":"312","author":"TIMI Study Group","year":"1985","unstructured":"TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932\u20136.","journal-title":"N Engl J Med"},{"issue":"21","key":"722_CR20","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/01.CIR.0000147778.05979.E6","volume":"110","author":"R Schroder","year":"2004","unstructured":"Schroder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation. 2004;110(21):e506\u201310.","journal-title":"Circulation"},{"key":"722_CR21","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, 2011. Available from www. cochrane-handbook.org ."},{"issue":"5","key":"722_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Mak. 2013;33(5):607\u201317.","journal-title":"Med Decis Mak"},{"issue":"5","key":"722_CR23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0272989X13485157","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Mak. 2013;33(5):618\u201340.","journal-title":"Med Decis Mak"},{"issue":"6","key":"722_CR24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jclinepi.2013.11.006","volume":"67","author":"SH Tan","year":"2014","unstructured":"Tan SH, Cooper NJ, Bujkiewicz S, Welton NJ, Caldwell DM, Sutton AJ. Novel presentational approaches were developed for reporting network meta-analysis. J Clin Epidemiol. 2014;67(6):672\u201380.","journal-title":"J Clin Epidemiol"},{"key":"722_CR25","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"issue":"1","key":"722_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MCA.0000000000000423","volume":"28","author":"HK Abdelaziz","year":"2017","unstructured":"Abdelaziz HK, Elkilany W, Khalid S, Sabet S, Saad M. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Coron Artery Dis. 2017;28(1):11\u20136.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"722_CR27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1536\/ihj.47.351","volume":"47","author":"T Akagi","year":"2006","unstructured":"Akagi T, Sarazawa K, Inai Y, Kitagawa M, Takahashi N, Hamanaka I, et al. Continuous administration of nicorandil decreases QT dispersion during the chronic phase of acute myocardial infarction. Int Heart J. 2006;47(3):351\u201361.","journal-title":"Int Heart J"},{"issue":"5","key":"722_CR28","first-page":"389","volume":"62","author":"IF Akturk","year":"2014","unstructured":"Akturk IF, Yalcin AA, Biyik I, Sarikamis C, Caglar NT, Erturk M, et al. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction. Minerva Cardioangiol. 2014;62(5):389\u201397.","journal-title":"Minerva Cardioangiol"},{"issue":"5","key":"722_CR29","doi-asserted-by":"crossref","first-page":"887.e9","DOI":"10.1016\/j.ahj.2006.05.010","volume":"152","author":"G Amit","year":"2006","unstructured":"Amit G, Cafri C, Yaroslavtsev S, Fuchs S, Paltiel O, Abu-Ful A, et al. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 2006;152(5):887.e9\u201314.","journal-title":"Am Heart J"},{"issue":"4","key":"722_CR30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MCA.0000000000000366","volume":"27","author":"S Bai","year":"2016","unstructured":"Bai S, Fu X, Gu X, Wang Y, Li W, Fan Y, et al. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2016;27(4):302\u201310.","journal-title":"Coron Artery Dis"},{"issue":"3","key":"722_CR31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/etm.2015.2623","volume":"10","author":"C Chen","year":"2015","unstructured":"Chen C, Fu X, Li W, Jia X, Bai S, Geng W, et al. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: a randomized factorial trial. Exp Ther Med. 2015;10(3):1059\u201365.","journal-title":"Exp Ther Med."},{"issue":"4","key":"722_CR32","first-page":"197","volume":"20","author":"JL Chen","year":"2008","unstructured":"Chen JL, Fu XH, Jiang YF, Fan WZ, Gu XS, Liu JJ, et al. Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008;20(4):197\u20139.","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"4","key":"722_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ehj.2013.08.001","volume":"66","author":"K Darahim","year":"2014","unstructured":"Darahim K, Mahdy MM, Ryan MM, Khashaba AA, Thabet SS, Hassan OM, et al. Does high-dose intracoronary adenosine improve regional systolic left ventricular function in patients with acute myocardial infarction? Egypt Heart J. 2014;66(4):289\u201397.","journal-title":"Egypt Heart J"},{"issue":"7","key":"722_CR34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/eurheartj\/ehq492","volume":"32","author":"W Desmet","year":"2011","unstructured":"Desmet W, Bogaert J, Dubois C, Sinnaeve P, Adriaenssens T, Pappas C, et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J. 2011;32(7):867\u201377.","journal-title":"Eur Heart J"},{"issue":"10","key":"722_CR35","first-page":"908","volume":"35","author":"WZ Fan","year":"2007","unstructured":"Fan WZ, Fu XH, Jiang YF, Gu XS, Wu WL, Li SQ, et al. Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(10):908\u201313.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"issue":"4","key":"722_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCINTERVENTIONS.109.858977.109.858977","volume":"2","author":"ML Fokkema","year":"2009","unstructured":"Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, de Smet BJ, et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Interv. 2009;2(4):323\u20139.","journal-title":"Circ Cardiovasc Interv."},{"issue":"3","key":"722_CR37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijcard.2014.09.203","volume":"177","author":"D Garcia-Dorado","year":"2014","unstructured":"Garcia-Dorado D, Garcia-del-Blanco B, Otaegui I, Rodriguez-Palomares J, Pineda V, Gimeno F, et al. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial. Int J Cardiol. 2014;177(3):935\u201341.","journal-title":"Int J Cardiol"},{"issue":"8","key":"722_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.amjcard.2010.12.010","volume":"107","author":"M Grygier","year":"2011","unstructured":"Grygier M, Araszkiewicz A, Lesiak M, Janus M, Kowal J, Skorupski W, et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 2011;107(8):1131\u20135.","journal-title":"Am J Cardiol"},{"key":"722_CR39","first-page":"294065","volume":"2014","author":"MA Hamza","year":"2014","unstructured":"Hamza MA, Galal A, Suweilam S, Ismail M. Local intracoronary eptifibatide versus mechanical aspiration in patients with acute ST-elevation myocardial infarction. Int J Vasc Med. 2014;2014:294065.","journal-title":"Int J Vasc Med"},{"issue":"1","key":"722_CR40","first-page":"32","volume":"18","author":"A Hendler","year":"2006","unstructured":"Hendler A, Aronovich A, Kaluski E, Zyssman I, Gurevich Y, Blatt A, et al. Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow. J Invasive Cardiol. 2006;18(1):32\u20136.","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"722_CR41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2012.06.015","volume":"164","author":"D Huang","year":"2012","unstructured":"Huang D, Qian J, Ge L, Jin X, Jin H, Ma J, et al. Restoration of coronary flow in patients with no-reflow after primary coronary intervention of acute myocardial infarction (RECOVER). Am Heart J. 2012;164(3):394\u2013401.","journal-title":"Am Heart J"},{"issue":"51","key":"722_CR42","first-page":"10399","volume":"11","author":"ZG Ji","year":"2007","unstructured":"Ji ZG, Han JM, Liu G, Liu KS. Effect of adenosine on ischemia-reperfusion injury during percutaneous coronary intervention. J Clin Rehabil Tissue Eng Res. 2007;11(51):10399\u2013403.","journal-title":"J Clin Rehabil Tissue Eng Res"},{"issue":"9","key":"722_CR43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1253\/circj.CJ-08-0212","volume":"72","author":"HC Lee","year":"2008","unstructured":"Lee HC, An SG, Choi JH, Lee TK, Kim J, Kim JH, et al. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction. Circ J. 2008;72(9):1425\u20139.","journal-title":"Circ J"},{"issue":"6","key":"722_CR44","first-page":"640","volume":"32","author":"Y Li","year":"2016","unstructured":"Li Y, Li Q, Li F, Zong M, Miao G, Yang X, et al. Evaluation of short- and long-term efficacy of combined intracoronary administration of high-dose adenosine and tirofiban during primary percutaneous coronary intervention. Acta Cardiol Sin. 2016;32(6):640\u20138.","journal-title":"Acta Cardiol Sin"},{"issue":"18","key":"722_CR45","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.101.18.2154","volume":"101","author":"M Marzilli","year":"2000","unstructured":"Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101(18):2154\u20139.","journal-title":"Circulation"},{"issue":"2","key":"722_CR46","first-page":"211","volume":"2","author":"A Miyazawa","year":"2006","unstructured":"Miyazawa A, Ikari Y, Tanabe K, Nakajima H, Aoki J, Iijima R, et al. Intracoronary nicorandil prior to reperfusion in acute myocardial infarction. EuroIntervention. 2006;2(2):211\u20137.","journal-title":"EuroIntervention"},{"issue":"3","key":"722_CR47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1253\/circj.68.192","volume":"68","author":"M Nameki","year":"2004","unstructured":"Nameki M, Ishibashi I, Miyazaki Y, Sakai Y, Namikawa S, Kuriyama N, et al. Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction. Circ J. 2004;68(3):192\u20137.","journal-title":"Circ J"},{"issue":"2","key":"722_CR48","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jcin.2012.12.023","volume":"6","author":"AE Nayel","year":"2013","unstructured":"Nayel AE, Elabd AA, Fathalla H. Role of intracoronary injection of Na-nitroprusside in preventing no-reflow phenomenon in patients with STEMI during primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2013;6(2):S7\u20138.","journal-title":"JACC Cardiovasc Interv."},{"issue":"24","key":"722_CR49","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","volume":"37","author":"SA Nazir","year":"2016","unstructured":"Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, et al. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J. 2016;37(24):1910\u20139.","journal-title":"Eur Heart J"},{"issue":"6","key":"722_CR50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jcin.2013.02.009","volume":"6","author":"G Niccoli","year":"2013","unstructured":"Niccoli G, Rigattieri S, De Vita MR, Valgimigli M, Corvo P, Fabbiocchi F, et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (intracoronary Nitroprusside versus adenosine in acute myocardial infarction). JACC Cardiovasc Interv. 2013;6(6):580\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"722_CR51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1253\/circj.70.1099","volume":"70","author":"S Ota","year":"2006","unstructured":"Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, et al. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart multicenter angioplasty revascularization trial (SMART). Circ J. 2006;70(9):1099\u2013104.","journal-title":"Circ J"},{"issue":"22","key":"722_CR52","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3760\/cma.j.issn.0366-6999.2009.22.008","volume":"122","author":"W Pan","year":"2009","unstructured":"Pan W, Wang LF, Yu JH, Fan Y, Yang SS, Zhou LJ, et al. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction. Chin Med J. 2009;122(22):2718\u201323.","journal-title":"Chin Med J"},{"issue":"8","key":"722_CR53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MCA.0000000000000167","volume":"25","author":"Y Peng","year":"2014","unstructured":"Peng Y, Fu X, Li W, Geng W, Xing K, Ru L, et al. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction. Coron Artery Dis. 2014;25(8):645\u201352.","journal-title":"Coron Artery Dis"},{"issue":"5","key":"722_CR54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ahj.2005.07.012","volume":"150","author":"AS Petronio","year":"2005","unstructured":"Petronio AS, De Carlo M, Ciabatti N, Amoroso G, Limbruno U, Palagi C, et al. Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine. Am Heart J. 2005;150(5):1015.","journal-title":"Am Heart J"},{"issue":"4","key":"722_CR55","first-page":"185","volume":"17","author":"Z Qiao","year":"2009","unstructured":"Qiao Z, Pu J, Ding S, Song W, Du Y, Shen J, et al. Effect of intracoronary verapamil on coronary flow, myocardial perfusion and clinical outcome during percutaneous coronary intervention for acute myocardial infarction. Chin J Intervent Cardiol. 2009;17(4):185\u201390.","journal-title":"Chin J Intervent Cardiol"},{"issue":"14","key":"722_CR56","doi-asserted-by":"crossref","first-page":"E988","DOI":"10.1016\/S0735-1097(11)60988-1","volume":"57","author":"S Sai","year":"2011","unstructured":"Sai S, Fischer L, Shivkumar J, Shivkumar J, Vishnuarunachalam R. Impact of intracoronary administration of nitroprusside vs. nitroglycerine before balloon dilatation on slow reflow during percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol. 2011;57(14):E988.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"722_CR57","doi-asserted-by":"crossref","first-page":"32B","DOI":"10.1016\/j.amjcard.2010.01.111","volume":"105","author":"N Shinozaki","year":"2010","unstructured":"Shinozaki N, Ichinose H, Hiramori S, Yahikozawa K, Hoshino K. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2010;105(9):32B.","journal-title":"Am J Cardiol"},{"issue":"3","key":"722_CR58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ccd.21334","volume":"71","author":"MG Stoel","year":"2008","unstructured":"Stoel MG, Marques KM, de Cock CC, Bronzwaer JG, von Birgelen C, Zijlstra F. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study. Catheter Cardiovasc Interv. 2008;71(3):283\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"722_CR59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4070\/kcj.2008.38.2.95","volume":"38","author":"GA Sung","year":"2008","unstructured":"Sung GA, Tae IP, Ki WH, Choi JH, Tae KL, Han CL, et al. The effect of intra-coronary nicorandil prior to reperfusion in acute ST segment elevation myocardial infarction. Korean Circ J. 2008;38(2):95\u2013100.","journal-title":"Korean Circ J"},{"issue":"5","key":"722_CR60","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0735-1097(97)00277-5","volume":"30","author":"Y Taniyama","year":"1997","unstructured":"Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997;30(5):1193\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"722_CR61","first-page":"839","volume":"41","author":"ZC Tong","year":"2013","unstructured":"Tong ZC, Li Q, Chen M, Miao GB, Wei Y, Li FO, et al. Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41(10):839\u201344.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"9","key":"722_CR62","first-page":"76","volume":"12","author":"X Wang","year":"2008","unstructured":"Wang X, Ding Z, Chen J. Role of adenosine in primary percutaneous coronary intervention. J Clin Med In Pract. 2008;12(9):76\u20137.","journal-title":"J Clin Med In Pract"},{"issue":"9","key":"722_CR63","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00380-015-0752-3","volume":"31","author":"K Yamada","year":"2016","unstructured":"Yamada K, Isobe S, Ishii H, Yokouchi K, Iwata H, Sawada K, et al. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging. Heart Vessel. 2016;31(9):1430\u20137.","journal-title":"Heart Vessel"},{"issue":"2","key":"722_CR64","first-page":"111","volume":"65","author":"L Yang","year":"2017","unstructured":"Yang L, Mu L, Sun L, Qi F, Guo R. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients. Minerva Cardioangiol. 2017;65(2):111\u20138.","journal-title":"Minerva Cardioangiol"},{"issue":"2","key":"722_CR65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejim.2008.06.007","volume":"20","author":"DK Yao","year":"2009","unstructured":"Yao DK, Jia SQ, Wang L, Li HW, Zhang YC, Wang YL, et al. Therapeutic effect of urapidil on myocardial perfusion in patients with ST-elevation acute coronary syndrome. Eur J Intern Med. 2009;20(2):152\u20137.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"722_CR66","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3892\/etm.2013.1139","volume":"6","author":"YJ Zhao","year":"2013","unstructured":"Zhao YJ, Fu XH, Ma XX, Wang DY, Dong QL, Wang YB, et al. Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction. Exp Ther Med. 2013;6(2):479\u201384.","journal-title":"Exp Ther Med"},{"issue":"7","key":"722_CR67","doi-asserted-by":"crossref","first-page":"e002258","DOI":"10.1161\/CIRCINTERVENTIONS.114.002258","volume":"8","author":"IY Elgendy","year":"2015","unstructured":"Elgendy IY, Huo T, Bhatt DL, Bavry AA. Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ Cardiovasc Interv. 2015;8(7):e002258.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"722_CR68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12872-016-0285-4","volume":"16","author":"R El Dib","year":"2016","unstructured":"El Dib R, Spencer FA, Suzumura EA, Goma H, Kwong J, Guyatt GH, et al. Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016;16(1):121.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"722_CR69","first-page":"295","volume":"28","author":"YY Wei","year":"2008","unstructured":"Wei YY, Fu XH, Liu J. Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(4):295\u20139.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1\u20133","key":"722_CR70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(02)01374-2","volume":"439","author":"FL Norby","year":"2002","unstructured":"Norby FL, Ren J. Anisodamine inhibits cardiac contraction and intracellular ca(2+) transients in isolated adult rat ventricular myocytes. Eur J Pharmacol. 2002;439(1\u20133):21\u20135.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"722_CR71","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","volume":"30","author":"DG Hottinger","year":"2014","unstructured":"Hottinger DG, Beebe DS, Kozhimannil T, Prielipp RC, Belani KG. Sodium nitroprusside in 2014: a clinical concepts review. J Anaesthesiol Clin Pharmacol. 2014;30(4):462\u201371.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"5","key":"722_CR72","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2165\/00003495-199651050-00007","volume":"51","author":"RN Brogden","year":"1996","unstructured":"Brogden RN, Benfield P. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs. 1996;51(5):792\u2013819.","journal-title":"Drugs"},{"issue":"8","key":"722_CR73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2459\/JCM.0b013e3283542031","volume":"13","author":"A Wang","year":"2012","unstructured":"Wang A, Chen F, Xie Y, Guo Z, Yu Y. Protective mechanism of nicorandil on rat myocardial ischemia-reperfusion. J Cardiovasc Med (Hagerstown). 2012;13(8):511\u20135.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"23","key":"722_CR74","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/01.CIR.0000040998.88272.A7","volume":"106","author":"L Gregorini","year":"2002","unstructured":"Gregorini L, Marco J, Farah B, Bernies M, Palombo C, Kozakova M, et al. Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation. 2002;106(23):2901\u20137.","journal-title":"Circulation"},{"issue":"2","key":"722_CR75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/cvr\/cvp033","volume":"83","author":"K Boengler","year":"2009","unstructured":"Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res. 2009;83(2):247\u201361.","journal-title":"Cardiovasc Res"},{"issue":"13","key":"722_CR76","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","volume":"376","author":"PC Smits","year":"2017","unstructured":"Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376(13):1234\u201344.","journal-title":"N Engl J Med"},{"key":"722_CR77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12872-015-0004-6","volume":"15","author":"T Aksu","year":"2015","unstructured":"Aksu T, Guler TE, Colak A, Baysal E, Durukan M, Sen T, et al. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2015;15:10.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:46:22Z","timestamp":1719747982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0722-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0722-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"article-number":"3"}}